Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Prognostic Value of Blood Biomarkers for Patients With Polyneuropathy.

NCT06044662 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.

NCT NCT06044662
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06044662 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Prognostic Value of Blood Biomarkers for Patients With Polyneuropathy.
Lead sponsor
Rigshospitalet, Denmark
Phase
Observational
Overall status
Recruiting
Start date
October 27, 2023
Completion date
October 31, 2026
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

polyneuropathies